| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mereo BioPharma Group plc | Chief Scientific Officer | Share Options (Right to buy) | 145,000 | $117,160 | $1.01 | 01 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MREO | Mereo BioPharma Group plc | 01 Feb 2026 | 3 | $0 | 4 | Chief Scientific Officer | 02 Feb 2026, 16:30 |
| MREO | Mereo BioPharma Group plc | 25 Jan 2025 | 1 | $0 | 4 | Chief Scientific Officer | 28 Jan 2025, 16:05 |
| MREO | Mereo BioPharma Group plc | 12 Sep 2024 | 2 | -$69,477 | 4 | Chief Scientific Officer | 16 Sep 2024, 20:49 |
| MREO | Mereo BioPharma Group plc | 11 Sep 2024 | 2 | $0 | 4 | Chief Scientific Officer | 13 Sep 2024, 16:49 |
| MREO | Mereo BioPharma Group plc | 25 Jun 2024 | 2 | -$84,427 | 4 | Chief Scientific Officer | 27 Jun 2024, 16:15 |
| MREO | Mereo BioPharma Group plc | 21 Jun 2024 | 2 | $0 | 4 | Chief Scientific Officer | 25 Jun 2024, 18:21 |
| MREO | Mereo BioPharma Group plc | 25 Jan 2024 | 1 | $0 | 4 | Chief Scientific Officer | 26 Jan 2024, 16:15 |
| MREO | Mereo Biopharma Group plc | 01 Jan 2024 | 0 | $0 | 3 | Chief Scientific Officer | 02 Jan 2024, 16:15 |